Images
Chromogenic <i>In Situ</i> Hybridization (FFPE Tissue)
Application

Chromogenic In Situ Hybridization (FFPE Tissue)

(A) microRNA in situ hybridization analysis of Hsa-miR-21-5p miRNA Probe (DIG) showing positive staining on FFPE human testis, liver and breast cancer tissues.
(B) microRNA in situ hybridization analysis of Hsa-miR-21-5p miRNA Probe (DIG) showing negative staining on FFPE human pancreas tissue and the negative controls on FFPE testis, liver and breast cancer tissues in the absence of probe (No Probe) followed by incubation with primary antibody, secondary antibody and detection reagents.

  • Specification

    Product Description

    Hsa-miR-21-5p miRNA Probe (DIG) designed from mature human miR-21 sequence.miRNA Probe,miRNA Probes

    miRbase ID

    MIMAT0000076

    Origin

    Human

    Reactivity

    Human

    Form

    Liquid

    Conjugation

    Digoxigenin (DIG)

    Notice

    Use of FFPE miRNA ISH Pretreatment Solution for the pretreatment of formalin-fixed paraffin-embedded (FFPE) tissue sections is strongly recommended.

    Regulation Status

    For research use only (RUO)

    Supplied Product

    10 reactions, 100 uL miRNA probe

    Storage Instruction

    Store at 4°C.

  • Applications

    Chromogenic In Situ Hybridization (FFPE Tissue)

    (A) microRNA in situ hybridization analysis of Hsa-miR-21-5p miRNA Probe (DIG) showing positive staining on FFPE human testis, liver and breast cancer tissues.
    (B) microRNA in situ hybridization analysis of Hsa-miR-21-5p miRNA Probe (DIG) showing negative staining on FFPE human pancreas tissue and the negative controls on FFPE testis, liver and breast cancer tissues in the absence of probe (No Probe) followed by incubation with primary antibody, secondary antibody and detection reagents.